Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study - Chong, B H; Gallus, A S; Cade, J F; Magnani, H; Manoharan, A; Oldmeadow, M; Arthur, C; Rickard, K; Gallo, J; Lloyd, J; Seshadri, P; Chesterman, C N (Thrombosis and haemostasis, 2001)
Keywords: Aged; Chondroitin Sulfates - administration & dosage; Chondroitin Sulfates - toxicity; Dermatan Sulfate - administration & dosage; Dermatan Sulfate - toxicity; Dextrans - administration & dosage; Dextrans - toxicity; Drug Combinations; Drug Therapy, Combination; Female; Heparin - adverse effects; Heparin - immunology; Heparitin Sulfate - administration & dosage; Heparitin Sulfate - toxicity; Humans; Male; Middle Aged; Prospective Studies; Survival Rate; Therapeutic Equivalency; Thrombocytopenia - chemically induced; Thrombocytopenia - complications; Thrombocytopenia - drug therapy; Thrombosis - complications; Thrombosis - drug therapy; Thrombosis - etiology; Treatment Outcome; Warfarin - administration & dosage